or Try an Advanced Search...

    Non Pharmaceutical Products Stocks List

    Symbol Grade Name % Change
    PFE D Pfizer, Inc. -0.97
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Alzheimer's Disease Animal Health Anti Infectives Biopharmaceutical Clinic Depressive Disorder Dietary Supplement Disease Dysfunction Endocrine Disorders Erectile Dysfunction Genitourinary Hemophilia Hypertension Inflammation Livestock Producers Major Depressive Disorder Medication Neuroscience Ophthalmology

    Related ETFs - A few ETFs which own one or more of the above listed Non Pharmaceutical Products stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 13.4
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 7.89
    FDL A First Trust Morningstar ETF 7.66
    PJP A PowerShares Dynamic Pharmaceuticals 5.91
    RDIV B RevenueShares Ultra Dividend Fund 5.32
    View all Non Pharmaceutical Products ETFs...
    Compare ETFs
    Compare FDL to RDIV Compare FTXH to PJP Compare HDLB to PJP

        Non Pharmaceutical Products Stocks Recent News

        Date Stock Title
        May 17 PFE 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
        May 17 PFE European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
        May 17 PFE Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 PFE Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
        May 17 PFE Pfizer Stock: Rebound Has Started (Technical Analysis)
        May 17 PFE Pfizer: Potential Double-Digit Upside Combined With High Dividend Yield
        May 16 PFE Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
        May 16 PFE 2 Top Growth Stocks Down 24% and 50% to Buy With $100
        May 16 PFE Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
        May 16 PFE Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report
        May 16 PFE UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
        May 16 PFE Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
        May 15 PFE Dividend picks by SA analysts: PFE, DVN, SBUX and LOW
        May 15 PFE Pfizer: Best Trading Momentum Since 2021 And 6% Yield
        May 15 PFE 3 No-Brainer Stocks to Buy With $500 Right Now
        May 14 PFE 2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
        May 14 PFE NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
        May 13 PFE Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
        May 13 PFE AstraZeneca, Pfizer to invest combined $900M+ in France for R&D, production
        May 13 PFE One stock is dragging down the S&P 500's earnings growth
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Alzheimer's Disease Animal Health Anti Infectives Biopharmaceutical Clinic Depressive Disorder Dietary Supplement Disease Dysfunction Endocrine Disorders Erectile Dysfunction Genitourinary Hemophilia Hypertension Inflammation Livestock Producers Major Depressive Disorder Medication Neuroscience Ophthalmology
        Non Pharmaceutical Products

        Browse All Tags